Sort by
Sort by

Nestlé Health Science to help stroke patients suffering from swallowing disorders

scientist at work

Nestlé Health Science announces its staged acquisition of Phagenesis, a medical device company that has developed an innovative treatment for stroke patients suffering from dysphagia (swallowing difficulties). The electrical stimulation device may also improve the swallowing dysfunction in patients in intensive care units.

The staged acquisition will be based upon the successful completion of clinical development programs by 2019.

Read the press release on Nestlé Health Science's website